aana glp-1 guidelines Glucagon-Like Peptide 1 Receptor Agonists and Aspiration Risk Most Patients Discontinue GLP-1 Drugs

In addition to antidiabetic medications, some may also be prescribed by medical professionals for the treatment and management of obesity

doi: 10.1159/000521264 Summary Keywords GLP-1R agonists, obesity, weight-reducing drugs, metabolic diseases, dual agonism Citation Wang J-Y, Wang Q-W, Yang X-Y, Yang W, Li D-R, Jin J-Y, Zhang H-C and Zhang X-F (2023) GLP1 receptor agonists for the treatment of obesity: Role as a promising approach

Potential Heart Failure Benefits: Offers advantages for heart failure patients, particularly those with preserved ejection fraction

doi: 10.1038/s12276-022-00736-w 89 YamazakiTHannaniDPoirier-ColameVLadoireSLocherCSistiguAet al

GltT was required for meningococcal survival within phagocytic cells (Tal et al., 2011) and in human whole blood (Li et al., 2009)